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INTRODUCTION
Noncompliance with prescribed drug regimens is a major obstacle to the
treatment of chronic diseases, including glaucoma. The long-term treatment
of this asymptomatic condition provides no subjective improvement, is
expensive, and may be associated with unpleasant side effects. All these
factors contribute to discourage patients from using the medications that
have been prescribed(1).
Several studies have suggested a positive relationship between incor-
rect usage of medication and ignorance about the disease(2-4). Others have
demonstrated that increasing patients’ knowledge about their disease and
“tailoring” the therapeutic regimen into the patients’ daily life effectively
increased correct usage of medication(5-10).
It has been reported that glaucoma patients have little understanding of
their disease and its treatment(2-4,11-12), but there are few studies assessing
this information directly. In a previous study, some of us reported that the
Patient education in glaucoma: what do patients know
about glaucoma?
Keywords: Patient education; Glaucoma; Physician-patient relations
Purpose: To evaluate the knowledge glaucoma patients have about their
disease and its treatment. Methods: One hundred and eighty-three
patients were interviewed at the Glaucoma Service of Wills Eye Hospital
(Philadelphia, USA, Group 1) and 100 at the Glaucoma Service of University
of Campinas (Campinas, Brazil, Group 2). An informal, relaxed atmosphere
was created by the interviewer before asking a list of 18 open-ended
questions. Results: In Group 1, 44% of the 183 patients did not have an
acceptable idea about what glaucoma is, 30% did not know the purpose
of the medications they were taking, 47% were not aware of what was an
average intraocular pressure, and 45% did not understand why visual
fields were examined. In Group 2, 54% gave unsatisfactory answers to the
question “What is glaucoma?”, 54% did not know the purpose of the
medications they were taking, 80% were not aware of what was an average
intraocular pressure, and 94% did not understand why visual fields were
examined (p<0.001). Linear regression analysis demonstrated that level
of education was positively correlated to knowledge about glaucoma in
both groups (r=0.65, p=0.001). Conclusions: This study showed that
patients’ knowledge about glaucoma varies greatly, and that in an urban,
American setting, around one third of the patients have minimal unders-
tanding, whereas in an urban setting in Brazil around two thirds of
patients were lacking basic information about glaucoma. Innovative and
effective methods are needed to correct this situation.
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knowledge glaucoma patients had in Campinas was unsatis-
factory(13). The immediate objective of the present study was
to compare the knowledge glaucoma patients in two different
countries have about their disease and its treatment. The
broader goal was to learn about factors that affect how glau-
coma patients care for themselves, and even more broadly, to
understand how to promote the health of patients.
METHODS
Between January and April 1994, patients with primary open
angle glaucoma (POAG) were interviewed at two institutions.
One hundred and eighty-three patients were interviewed at the
Glaucoma Service of Wills Eye Hospital (Philadelphia, USA,
Group 1) and 100 at the Glaucoma Service of the University of
Campinas (Campinas, Brazil, Group 2). In Philadelphia, the
subjects were from both a glaucoma clinic and a private prac-
tice, whereas patients in Campinas were exclusively from a
glaucoma clinic. Each patient was interviewed by one of two
investigators (C.N.U. and J.P.C.V.) during a routine office visit.
An informal, relaxed atmosphere was created by the interviewer
before asking the following list of open-ended questions:
01) Which eye disease do you have?
02) When did you first learn you had glaucoma?
03) When you first learned you had glaucoma, did you
have any difficulty with your vision?
04) (If the answer to question 3 is yes). What kind of
difficulty did you have with your vision?
05) Do you take medications - pills or eyedrops - for your
eyes?
06) What is (are) the name (s) of the medications you take?
How many times a day do you take it (them)?
07) Do you always take all your medicines?
08) Have you ever stopped the medication on your own?
09) (If the answer to question 8 is yes). Why did you stop
the medication?
10) Do the medicines have side effects?
11) Have the side effects of the medications been explai-
ned to you?
12) What is glaucoma?
13) Do you know your intraocular pressure at your last visit?
14) What is an average intraocular pressure? That is, if you
measure the intraocular pressure in 100 people, what
would be the most common pressure?
15) What is the purpose of the medications you use?
16) Does glaucoma cause blindness?
17) Why is the visual field measured?
18) Is it important to have your relatives examined?
The answers given by the patients to questions #12, 14, 15,
and 17 were classified as unsatisfactory or satisfactory. For
question # 12, satisfactory answers included:
• It is a disease caused by high intraocular pressures.
• It is a disease that affects the optic nerve.
• It is a disease that affects the visual field.
For question # 14, satisfactory answers included:
• Any number between 10 and 20.
For question # 15, satisfactory answers included:
• To lower intraocular pressure.
• To prevent progression of glaucoma.
For question # 17, satisfactory answers included:
• Because optic nerve damage leads to visual field damage.
• Because the visual field can be affected in patients with
glaucoma.
• To analyze glaucoma progression.
All other substantially different answers given to these
questions were considered unsatisfactory.
Statistical analyses were performed with Student’s "t" test
or the Kruskall Wallis test for continuous variables and the chi
square (Yates corrected) or Fisher’s exact test for categorical
variables. Linear regression analysis was performed to evaluate
variables associated with lack of knowledge. P values of less
than 0.05 were considered significant.
RESULTS
Table 1 describes the demographics of both populations.
Sex and race distributions were found to be similar between
the groups, but patients in Group 1 were significantly older
Table 1. General characteristics of the population
Wills Eye Hospital (n=183) UNICAMP (n=100)      p
Sex F= 110     M= 73 F= 52     M= 48 <0.233
Race W= 109     B= 70     A= 4 W= 61     B= 39     A= 0 <0.329
Age (years) 69.1 ± 16.2 63.1 ± 10.1 <0.001*
Instruction level
Illiterate 03 36 <0.0001*
High school 89 56
College 91 08
Time of diagnosis (years) 10.6 ± 9.70 003.8 ± 1.20 <0.0001*
Distance from office (km) 81.0 ± 60.8 122.6 ± 35.8 <0.0001*
F= Female; M= Male; W= White; B= Black; A= Asian
*= p<0.05
69(6)31.p65 15/12/06, 15:13924
Arq Bras Oftalmol. 2006;69(6):923-7
Patient education in glaucoma: what do patients know about glaucoma?  925
than in Group 2 (p=0.001), those in Group 2 tended to live
further away from the office (122.6 ± 35.8 km) than those in
Group 1 (81.0 ± 60.8 km) (p<0.0001). Patients in Group 1 had
glaucoma longer than in Group 2 (10.6 ± 9.7 years, and 3.8 ± 1.2
years, respectively) (p<0.0001), and had reached a higher edu-
cational level than patients in Group 2 (p<0.0001).
Table 2 displays the answers to questions related to the
way patients felt about their eye disease. One hundred seven-
ty-three patients in Group 1 (95%) and 70 of the 100 patients in
Group 2 (70%) knew they had glaucoma (p<0.0001). A signifi-
cantly higher percentage of patients in Group 1 (51%,
compared to 33% in Group 2) indicated that they had
experienced vision difficulty when they first learned they had
glaucoma (p=0.012). In both groups, the main difficulties
included blurry vision, difficulty reading, and misty vision.
Table 3 shows the patients’ knowledge about the medica-
tions they were using. One hundred and seventy patients in
Group 1 and 95 patients in Group 2 were under antiglaucoma
therapy. Twelve patients in Group 1 (7%) and 20 patients in
Group 2 (21%) neglected to always take their medicines
(p=0.001). In Group 1, among the 170 patients who took medi-
cations, 97% were using betablockers, 64% pilocarpine, 34%
dipivalil-epinephrine, 10% apraclonidine, and 19% carbonic
anhydrase inhibitors. In Group 2, among the 95 patients recei-
ving medications, 95% took betablockers, 52% pilocarpine,
20% dipivalyl-epinephrine, and 12% carbonic anhydrase inhi-
bitors. Fifty-two patients in Group 1 (31%) and 51 patients in
Group 2 (54%) did not know the purpose of the medications
they were taking (p=0.0002). In Group 1, 22 (12%) patients
indicated stopping their medications on their own, the main
reasons being: side effects (n=7), no apparent effect noted by
the patient (n=6), or no improvement noted by the patient
(n=3). In Group 2, 21 (21%) had stopped their medications, due
to economic reasons (n=10), side effects (n=7), and absence of
change (n=2). One hundred twelve (61%) patients in Group 1
and 68 (68%) patients in Group 2 (p=0.313) could not remember
any discussion of possible side effects.
Eighty-one patients from Group 1 (44.3%) and 54 patients in
Group 2 (54%) gave unsatisfactory answers to the question
“What is glaucoma?” (p=0.1489). A larger percentage of patients
in Group 2 (35%) than in Group 1 (8%) did not know that glau-
coma may cause blindness (p<0.0001). When questioned about
intraocular pressure, 60 patients in Group 1 (33%) and 75 patien-
ts in Group 2 (75%) did not know their last intraocular pressure
measurement (p<0.0001). Eighty-seven patients in Group 1
(48%) and 80 patients (80%) in Group 2 were not aware of what
Table 2. Questions related to the way patients felt about their eye disease
Questions Wills Eye Hospital (n=183) UNICAMP (n=100)      p
What eye disease do you have? <0.0001*
Glaucoma 173 70
Other / None 010 30
Did you have difficulty with your vision? Y= 93     N= 90 Y= 67     N= 33 <0.012*
What kind of difficulty? <0.426
Blurry vision 047 45
Difficulty reading 013 11
Misty vision 009 06
Others 029 15
Y= Yes; N= No
*= p<0.05
Table 3. Questions related to the use of medications
Questions Wills Eye Hospital (n=183) UNICAMP (n=100)    p
Do you take medications for your eyes? Y= 170 N= 13 Y= 95 N= 5 0.661
Do you always take all your medicines? Y= 158 N= 12 Y= 75 N= 20 0.001*
Which medications? 0.019*
Betablockers 165 90
Pilocarpine 108 49
Dipivalyl-epinephrine 057 19
Apraclonidine 017 00
C.A.I. 032 11
Have you ever stopped the medication? Y= 022 N= 161 Y= 21 N= 79 0.066
What is the purpose of the medications? S= 131 U= 052 S= 49 U= 51 0.0002*
Do the medicines have side effects? Y= 081 N= 102 Y= 48 N= 52 0.632
Have the side effects been explained? Y= 071 N= 112 Y= 32 N= 68 0.313
Y= Yes; N= No; S= Satisfactory answer; U= Unsatisfactory answer; C.A.I.= Carbonic anhydrase Inhibitors
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constitutes an average intraocular pressure (p<0.0001). Eighty-
four patients in Group 1 (45%) and 94 patients in Group 2 (94%)
gave unsatisfactory reasons as to why the visual field is exa-
mined (p<0.0001). A smaller proportion of patients from Group 2
(27%) indicated that they knew the importance of screening
their relatives for glaucoma (Group 1 - 61.7%) (p<0.0001).
Linear regression analysis demonstrated that level of edu-
cation was positively correlated to knowledge about glauco-
ma in both groups (r=0.65, p=0.001). Other variables, including
age, sex, race, time of diagnosis, and distance from the office
were not associated with lack of knowledge.
DISCUSSION
Compliance, a term routinely used to define “correct use of
medications as ordered by the physician”, is a complex problem
that may be influenced by a variety of factors such as instilla-
tion technique, complexity of drug regimens, costs and side
effects of medications, and doctor-patient relationship(1,4). Se-
veral studies have demonstrated a relationship between know-
ledge and correct use of medications(2,4,6). We wished to revisit
this issue, specifically comparing populations from two diffe-
rent cultures, to search for commonalities and differences that
might help doctors work with patients in a way more likely to
result in good self care, of which proper use of medications is
but one aspect.
The present study demonstrates that while there are signi-
ficant differences in certain characteristics of patients in glau-
coma in Philadelphia and Campinas, in both populations many
individuals are ignorant about their condition. In Philadelphia,
44% of the patients did not have an acceptable idea of what
glaucoma is, 31% did not know the purpose of the medications
they were taking, and 45% did not understand why visual
fields were examined. The situation was worse in Campinas:
54% gave unsatisfactory answers to the question “What is
glaucoma?”, 54% did not know the purpose of the medications
they were taking, and 94% did not understand why visual
fields were measured. The differences observed between Phi-
ladelphia and Campinas were, at least in part, secondary to a
disparity among educational levels, a finding that has also
been reported by Kim et al.(14).
In a previous study(2), conducted in the same American
institution in 1969, it was shown that 75% of the patients knew
they had glaucoma, and 38% had an idea of the nature of
glaucoma. In the present investigation, there was an improve-
ment in the proportions of patients who knew they had glauco-
ma (94%), and who had an acceptable idea about what glauco-
ma is (56%). Although comparisons between these two groups
interviewed at the same institution 25 years apart are limited, the
creation of a glaucoma clinic and an improved access to infor-
mation (including the Internet) may have played a role.
One or more of the following factors may justify the lack of
knowledge shown by two populations of glaucoma patients:
1) The doctor-patient relationship may be poor, preventing
the patient from receiving all the information that is being
given. Ophthalmologists should make an effort to avoid the
“activity-passivity” type of relationship, in which the patient
is passive and is acted on by the doctor. As suggested by
Riffenburgh(1), the relationship should begin with the “gui-
dance-cooperation” model, where the patient listens to the
doctor and follows his directions. As knowledge about the
disease increases, the doctor-patient relationship can gra-
dually change to the “mutual-participation” type, where the
physician helps the patient to help himself.
2) Patients may have a low concern about their health and
may be too diffident to ask questions. In our series, there is
evidence pointing to a lack of interest of the patients towards
their treatment: a) 5% in Group 1 and 30% in Group 2 were
unaware of having glaucoma, and b) 33 in Group 1 and 75% in
Group 2 did not know their last intraocular pressure measure-
ment. Encouraging patients to obtain the information they
require from their physicians has been shown to enhance the
doctor-patient relationship and the likelihood that medica-
tions are properly used(9,15).
3) Not enough information is being given. This may be
associated with little time dedicated to the discussion of the
disease during the consultation. Our series showed that 61%
of the patients in Group 1 and 68% of the patients in Group 2
under antiglaucoma medication did not receive explanations
about side effects.
4) The way the information is being given does not enable
the patient to understand it. Ophthalmologists have to be
flexible in the way they choose to explain the disease so that it
is in accordance with the education level of the patient. In
other areas, it has been shown that approximately one third of
all patients are dissatisfied with the communication aspect of
their consultations(16-17). Inui et al. suggested that, with brief
educational input, physicians could increase their skills as
communicators, thus leading to better knowledge levels(18).
In general, ophthalmologists do not have enough time to
give a detailed explanation to each and every patient coming
to their offices. Educational plans need to be developed to
increase patients’ knowledge about glaucoma. Videotapes
presenting basic information about glaucoma and its treat-
ment, accompanied by a booklet in which patients record
medications and instillation times have been suggested as
strategies to enhance patients’ education(6-7,11,19). Similarly,
ophthalmic assistants can be instructed to explain the basics
of glaucoma and its treatment to small groups of patients(20).
This study was limited to patient knowledge about glauco-
ma, its diagnosis and treatment. One aspect of human nature is
a disconnection between knowing and doing. Merely having
knowledge does not guarantee healthy behaviour. For exam-
ple, millions of people smoke cigarettes, even though they
know that smoking is unhealthy. Nevertheless, knowledge is
an important part of self care.
In spite of the remarkable developments in glaucoma treat-
ment and diagnosis, this progress is worthless if patients do
not care for themselves properly. Our study showed that few
glaucoma patients have a good understanding of the extent,
the treatment, and the prognosis of their disease, even in a
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practice devoted to glaucoma in a major American city. The
major factor determining whether patients with glaucoma re-
tain their sight or become blind is how they care for themsel-
ves. A part of their care is use of medications, with appropriate
frequency. Other factors are also important, such as returning
for appointments with the physician, and providing accurate
and pertinent history to the physician. The successful treat-
ment of glaucoma requires competent self-care. As healers, we
have a responsibility to help patients learn about their health,
including glaucoma, and to stimulate their participation in
their treatment. It seems appropriate to develop and study
innovative and effective methods to promote this concept.
RESUMO
Objetivo: Avaliar o conhecimento de pacientes glaucomato-
sos sobre sua doença e tratamento. Métodos: 183 pacientes
foram entrevistados no Serviço de Glaucoma do Wills Eye
Hospital (Philadelphia, EUA, Grupo 1) e 100 pacientes foram
entrevistados no Setor de Glaucoma da UNICAMP (Grupo 2).
Dezoito perguntas abertas foram feitas aos pacientes num
ambiente informal. Resultados: No Grupo 1, 44% dos 183 pa-
cientes não tinham conceito adequado sobre o que é glauco-
ma, 30% desconheciam porque usavam medicações, 47% não
sabiam valores de pressão intra-ocular considerados normais
e 45% não sabiam porque campos visuais eram testados. No
Grupo 2, 54% responderam inadequadamente à pergunta “O
que é glaucoma?”, 54% desconheciam porque usavam medi-
cações, 80% não sabiam valores de pressão intra-ocular con-
siderados normais e 94% não sabiam porque campos visuais
eram testados (p<0,001). Análise de regressão linear demons-
trou que o nível de educação estava positivamente correla-
cionado ao conhecimento de glaucoma em ambos os grupos
(r=0,65, p=0,001). Conclusões: Este estudo mostrou que o
conhecimento sobre glaucoma varia muito e que, num hospital
norte-americano, cerca de um terço dos pacientes tem compre-
ensão mínima sobre a doença, enquanto no Serviço brasileiro,
dois terços dos pacientes desconheciam conceitos básicos
sobre o glaucoma. Métodos efetivos e inovadores devem ser
desenvolvidos para melhorar essa situação.
Descritores: Educação do paciente; Glaucoma; Relações mé-
dico-paciente
REFERENCES
1. Riffenburgh RS. Doctor-patient relationship in glaucoma therapy. Arch Ophthal-
mol. 1966;75(2):204-6.
2. Spaeth GL. Visual loss in a glaucoma clinic. I. Sociological considerations.
Invest Ophthalmol. 1970;9(1):73-82.
3. MacKean JM, Elkington AR. Compliance with treatment of patients with
chronic open-angle glaucoma. Br J Ophthalmol. 1983;67(1):46-9.
4. Bour T, Blanchard F, Segal A. Observance thérapeutique et vécu du glaucome
primitif à angle ouvert. A propos de 341 cas dans la Marne. J Fr Ophtalmol.
1993;16(6-7):380-91.
5. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS,
Johnson AL. Improvement of medication compliance in uncontrolled hyperten-
sion. Lancet. 1976;1(7972):1265-8.
6. Norell SE. Improving medication compliance: a randomised clinical trial. Br
Med J. 1979;2(6197):1031-3.
7. Granstrom PA. Glaucoma patients not compliant with their drug thrapy: clini-
cal and behavioural aspects. Br J Ophthalmol. 1982;66(7):464-70.
8. DiMatteo MR, DiNicola DD. Achieving patient compliance: the psychology of
the medical practicioner’s role. New York: Pergamon; 1982.
9. Ley P. Doctor-patient communication: some quantitative estimates of the role of
cognitive factors in non-compliance. J Hypertens Suppl. 1985;3(1):S51-5. Review.
10. Van Buskirk EM. The compliance factor. Am J Ophthalmol. 1986;101(5):609-10.
11. Zimmerman TJ, Zalta AH. Facilitating patient compliance in glaucoma thera-
py. Surv Ophthalmol. 1983;28 Suppl: 252-8.
12. Michielutte R, Diseker RA, Stafford CL, Carr P. Knowledge of diabetes and
glaucoma in a rural North Carolina community. J Community Health. 1984;
9(4):269-84.
13. Costa VP, Vasconcelos JPC, Pelegrino M, José NK. O que os pacientes sabem
sobre glaucoma? Arq Bras Oftalmol. 1995;58(1):36-41.
14. Kim S, Mills RP, Leen MM, Stewart JF, Emond M. Glaucoma patient
education [abstract]. Invest Ophthalmol Vis Sci. 1996; 37 Suppl:S642. [Asso-
ciation for Research in Vision and Ophthalmology 1996 annual meeting. Fort
Lauderdale, Florida, April 21-26, 1996].
15. Roter DL. Patient participation in the patient-provider interaction: the effects of
patient question asking on the quality of interaction, satisfaction and complian-
ce. Health Educ Monogr. 1977;5(4):281-315.
16. Ley P. Satisfaction, compliance and communication. Br J Clin Psychol. 1982;
21(Pt 4):241-54.
17. Ley P. Giving information to patients. In: Eiser JR, editor. Social Psychology
and Behavioural Medicine. New York, Wiley, 1982, p.71-9.
18. Inui TS, Yourtee EL, Williamson JW. Improved outcomes in hypertension
after physician tutorials. A controlled trial. Ann Intern Med. 1976;84(6):646-51.
19. Rosenthal AR, Zimmerman JF, Tanner J. Educating the glaucoma patient. Br
J Ophthalmol. 1983;67(12):814-7.
20. Cintra FA, Costa VP, Tonussi JAG, José NK. Avaliação de programa educati-
vo para portadores de glaucoma. Rev Saúde Pública = J Public Health. 1998;32
(2):172-7.
69(6)31.p65 15/12/06, 15:13927
